Il Prof. Francesco Ricci è specialista in Dermatologia e venereologia con Dottorato di ricerca in Dermatologia Oncologica.

Da gennaio 2026 ricopre il ruolo di Professore associato (II fascia) di dermatologia presso Link University of Rome, Italy.

Attualmente il Prof. Francesco Ricci è Dirigente medico Dermatologo presso il Day surgery dermatologico e l’unità di chirurgia dermatologica e laserterapia dell’IDI-IRCCS di Roma.

Da maggio 2018 riveste l’incarico di Responsabile dell’Unità Operativa Funzionale del Melanoma IDI-IRCCS di Roma.

Si occupa principalmente di tumori cutanei (melanoma, cheratosi attinica, carcinoma basocellulare e squamocellulare), della valutazione dei nevi in epiluminescenza e della chirurgia dermatologica.

Prof. Francesco Ricci

  • Da Gennaio 2026 ad oggi: Professore associato (II fascia) di dermatologia presso Link University of Rome, Italy
  • 07/10/2022: abilitazione scientifica nazionale a Professore di II fascia settore concorsuale 06/D4 valido dal 07/10/2022 al 07/10/2034 (art. 16, comma 1, Legge 240/10)
  • Da Febbraio 2019 ad oggi: Dirigente Medico Dermatologo presso IDI-IRCCS FLMM
  • Da Maggio 2018 ad oggi: responsabile Unità Operativa Funzionale del Melanoma IDI-IRCCS, Roma
  • 2018 – 2021: Attività di docenza per il Master di Medicina Estetica Consorzio Universitario Humanitas – Università LUMSA (I e II edizione 2018/2020; moduli: Lentigo, Lesioni pigmentate e Melanoma) e attività di docenza per il Master di II livello di “Dermatologia clinica avanzata” (anno 2020-2021; moduli: tumori cutanei e melanoma) patrocinato dal “Consorzio universitario Humanitas”
  • Agosto 2017 – Gennaio 2019: Medico Dermatologo libero professionista presso il Day Surgery Dermatologico e l’Unità di Chirurgia Dermatologica e Laserterapia IDI-IRCCS FLMM
  • Novembre 2014 – Marzo 2018: Dottorato di ricerca in “Scienze Oncologiche” presso il Policlinico A. Gemelli di Roma (Coordinatore Prof. Barone C.) dove ho collaborato nell’ambulatorio oncologico Melanomi e Tumori cutanei non melanocitari contestualmente all’attività di sala operatoria (Direttore Prof. Ketty Peris)
  • Novembre-Dicembre 2015: Collaborazione libero professionale presso Clinical Epidemiology Unit, IDI-IRCCS – FLMM, Roma, Italy (Responsabile: Dr. Abeni D)
  • Maggio 2010 -14 Maggio 2015: Specializzazione in Dermatologia e Venereologia presso l’Università Cattolica del Sacro Cuore di Roma, titolo della Tesi: “Cheratosi attiniche e campo di cancerizzazione: il ruolo dell’ingenolo mebutato” (Relatore: Prof. Ketty Peris, Correlatore Prof. Rodolfo Capizzi), voto: 50/50 e lode
  • Settembre 2013 – Gennaio 2014: Vincitore del grant WEA-International Internships 2013 Medical fellow presso Akademisches Lehrkankenhaus der Johann-Wolfang-Goethe-Universitat Frankfurt/Main Hautklinik of Darmstadt-Eberstadt (Germany) Direttore Pr. Doz. Maurizio Podda dove mi sono occupato di oncologia dermatologica con particolare approfondimento in management dei pazienti affetti da tumori cutanei in fase avanzata e metastatica, tecnica del linfonodo sentinella, chirurgia dei tumori cutanei con tecnica di Mohs modificata, ricostruzione dei difetti chirurgici tramite lembi di rotazione, trasposizione, avanzamento ed innesti cutanei
  • Maggio 2013. Corso di perfezionamento in Dermochirurgia, laserchirurgia e tecniche dermoestetiche correlate – Università Cattolica del Sacro Cuore di Roma (Direttore del corso: Prof. Giuseppe Guerriero)
  • 09/03/2010: Iscrizione all’Albo dei Medici-Chirurghi di Roma con posizione N. 57979
  • 10 febbraio 2010: esame di stato per il conseguimento dell’idoneità all’esercizio della professione medico-chirurgica (votazione 265,75/270); Università Cattolica del Sacro Cuore di Roma
  • 21 luglio 2009: laurea in Medicina e Chirurgia conseguita presso l’Università Cattolica del Sacro Cuore di Roma, con votazione di punti 110/110 con Lode presentandosi con tesi di laurea sperimentale, relatore il Prof. Rodolfo Capizzi, correlatore la Dott.ssa C. Guerriero dal titolo: “Cetuximab e radioterapia nel trattamento dei carcinomi squamosi del distretto testa-collo: rassegna degli effetti collaterali di interesse dermatologico
  1. Selezionato da EADV per: “Training course Melanoma update and short Dermoscopy” Prof. Mirna Situm 14-16 Marzo 2014 Zagreb, Croatia
  2. Selezionato da EADV per: “Training course Paediatric Dermatology” Prof. Ramon Grimalt 14-15 Febbraio 2014 Barcelona, Spain
  3. Settembre 2013-Gennaio 2014: Vincitore del grant WEA-International Internships 2013 Medical fellow presso Akademisches Lehrkankenhaus der Johann-Wolfang-Goethe-Universitat Frankfurt/Main Hautklinik of Darmstadt-Eberstadt (Germany) Direttore Pr. Doz. Maurizio Podda
  4. Selezionato da EADV per: “Training course Systemic treatment in dermatology” Prof. Carle Paul 28-30 Agosto 2013 Toulose, France
  5. “Fundamentals of cutaneous oncology: first european school of dermato-oncology organized by EADO” Course directors: Prof. Claus Garbe-Prof. Axel Hauschild Berlin 17-19 Gennaio 2013
  6. November 2012: Selezionato per rappresentare l’Italia per EURODERME EXCELLENCE 2012 COURSE: “Dermato-venereology: from lab research to patient’s needs”. Rome 14-18 Novembre (President Prof. Harald Gollnick)
  1. Di Guardo A, Didona B, Ambrosio L, Ricci F, Panebianco A, Di Lella G, Abeni D, Fania L.Cutaneous leishmaniasis of the nose evaluated with confocal microscopy successfully treated with topical 5% imiquimod. JAAD Case Rep. 2025 Dec 17;69:210-213. doi: 10.1016/j.jdcr.2025.10.070. PMID: 41799351
  2. Pistore G, Ambrosio L, Di Guardo A, Panebianco AR, Di Lella G, Conforti C, Pellacani G, Moro F, Marchetti P, Abeni D, Fania L, Ricci F. Non-Invasive Assessment of Treatment Response in Actinic Keratosis: A Clinically Oriented Multimodal Review. Cancers (Basel). 2026 Feb 22;18(4):708. PMID: 41749961
  3. Michelini S, Scribani Rossi P, Gemma G, Persechino F, Vespasiani G, Conforti C, Ricci F, Cantisani C, Pellacani G. Assessing the Dermal Epidermal Junction of Hyperkeratotic Actinic Keratoses via Line-Field Confocal Optical Coherence Tomography.Int J Dermatol. 2026 Feb 11. PMID: 41670228
  4. Pistore G, Fania L, Pellacani G, Stanganelli I, Paolino G, Massone C, Di Lella G, Abeni D, Ricci F. Is ChatGPT a reliable informant? Dermatologists review AI-generated answers to frequently asked questions about melanoma. Dermatol Reports. 2026 Jan 21. PMID: 41563133
  5. Petrilli A, Barnaba D, Mancini M, Fania L, Ricci F, Dellambra E, Melino G, Candi E, Smirnov A. Solute carrier family (SLC) amino acid transporters are upregulated in cutaneous squamous cell carcinoma. Biol Direct. 2026 Jan 12. PMID: 41526979
  6. Di Guardo A, Trovato F, Cantisani C, Ricci F, Di Lella G, Moro F, Morese R, Panebianco A, Nisticò SP, Pellacani G, Fania L. Advanced Cutaneous Squamous Cell Carcinoma: Biology, Immunotherapy, and Evolving Prognostic Factors. Biomedicines. 2025 Dec 8;13(12):3010. PMID: 41463022
  7. Fania L, Pistore G, Perasole A, Strippoli D, Ricci F, Di Lella G, Samela T, Melandri D, Caproni M, Galdo G, Cota C, Massone C. Management of dysplastic nevus by Italian dermatologists: a survey of the Italian Association of Hospital Dermatologists (ADOI). Dermatol Reports. 2025. PMID: 41246966
  8. Hyeraci M, Didona D, Abeni D, Magri F, Ricci F, Bertagnin C, Loregian A, Di Lella G, Di Guardo A, Panebianco A, Chello C, Conforti C, Dellambra E, Fania L. New Insights into Pathogenesis and Management of Keratoacanthoma: A Narrative Review. Int J Mol Sci. 2025 Oct 15;26(20):10040. PMID: 41155332
  9. Ricci F, Pistore G, Di Lella G, Fania L, Ricci F, Rahimi S, Panebianco A, Fortes C, Abeni D. Getting even: occurrence of histopathological primitive melanoma diagnoses three years after the COVID-19 lockdown. Dermatol Reports. 2025 Jul 23. PMID: 40704372
  10. Properzi M, Dimartino V, Pietrucci D, Fontana C, Lembo L, Ricci F, Scatozza F, Di Lella G, Messina F, Chillemi G, Bartolini B, Facchiano A. Investigating Skin Microbial Community in Malignant Melanoma Lesions. Microorganisms 2025; 13(5), 992. PMID: 40431165
  11. Paolino G, Tosti G, Mascagni D, Di Nicola MR, Valenti M, Ardigò M, Cantisani C, Podo Brunetti A, Eberspacher C, Giacomelli L, Russo V, Melcarne R, Mistrangelo M, Quaglino P, Senetta R, Picciariello A, Vincenti L, Rega D, Delrio P, Caracò C, Portinaio M, Damiano G, Bulotta A, Rizzo N, Arcieri S, Rongioletti F, Carugno A, Di Ciaccio SM, Falcone R, Ricci F, Pampena R, Mercuri SR. Anorectal melanoma: Clinico-pathological features of a rare and aggressive malignancy in a multicentric study. J Eur Acad Dermatol Venereol. 2025 Mar 18. PMID: 40103352
  12. Ricci F, Pistore G, Di Lella G, Fania L, Rahimi S, Fortes C, Panebianco A, Abeni D. Synchronous melanomas: one on tattoo and one on healthy skin. Dermatol Reports. 2025 Feb 6. PMID: 39912612
  13.  Magri F, Fania L, Samela T, Ricci F, Di Lella G, D’Erme AM, Galdo G, Cusano F, Perasole A, Abeni D, Naldi L, Massone C. Lack of communication between dermatologists and histopathologists in real-life settings: a survey of the Italian Association of Hospital Dermatologists (ADOI). Dermatol Reports. 2024 Dec 5. PMID: 39969061
  14. Hyeraci M, Pistore G, Ricci F, Moro F, Lella GD, Dellambra E, Abeni D, Fania L. Cost-Effectiveness Analysis of Topical Treatments for Actinic Keratosis in Italian National Health System. J Clin Med. 2024 Oct 22;13(21):6312. PMID: 39518453
  15. Zamagni F, Falcini F, Magi S, Bucchi L, Mancini S, Vattiato R, Crocetti E, Falcinelli S, Feliciani C, Lombardo M, Melandri D, Pizzichetta MA, Re P, Ricci F, Satta RR, Gandini S, Stanganelli I. Preliminary analysis of the melanoma multimedia educational program for general practitioners on behalf of the Italian Melanoma Intergroup. Dermatol Reports. 2023 Sep 12;16(3):9920. PMID: 39290553
  16. Fortes C, Mastroeni S, Levati L, Alotto M, Ricci F, D’Atri S. The potential impact of dietary choices on melanoma risk: an anti-inflammatory diet. Genes Nutr. 2024 May 23;19(1):9. PMID: 38783228
  17. Paradisi A, Ciobotariu I, Quattrini L, Ricci F, Peris K. Linear atrophoderma of Moulin. J Dermatol. 2024. PMID: 38711276
  18. Ricci F, Fania L, Pistore G, Abeni D. Iris pattern as a marker of skin cancer risk. J Eur Acad Dermatol Venereol. 2024 Feb;38(2):243-244.  PMID: 38268398
  19. Samela T, Fania L, Sampogna F, Mastroeni S, Ricci F, Abeni D. Incidence of keratinocyte carcinomas in Italy: an exercise in indirect estimation based on melanoma data. Eur J Dermatol. 2023 Jun 1;33(3):230-234.  PMID: 37594327
  20. Hyeraci M, Papanikolau ES, Grimaldi M, Ricci F, Pallotta S, Monetta R, Minafò YA, Di Lella G, Galdo G, Abeni D, Fania L, Dellambra E. Systemic Photoprotection in Melanoma and Non-Melanoma Skin Cancer. Biomolecules. 2023 Jul 2;13(7):1067. PMID: 37509103
  21. Cappello A, Zuccotti A, Mancini M, Tosetti G, Fania L, Ricci F, Melino G, Candi E. Serine and one-carbon metabolism sustain non-melanoma skin cancer progression. Cell Death Discov. 2023 Mar 24;9(1):102. PMID: 36964165
  22. Fortes C, Mastroeni S, Zappalà AR, Passarelli F, Ricci F, Abeni D, Michelozzi P. Early inflammatory biomarkers and melanoma survival. Int J Dermatol. 2023 PMID: 36872079
  23. Ricci F, Fania L, Antonelli F, Ricci F, Perino F, Di Lella G, Pallotta S, Fortes C, Panebianco A, Abeni D. Melanoma on tattoos: a case study and review of the literature. Eur J Dermatol. 2022 Nov 1;32(6):703-708. PMID: 36856376
  24. Papanikolaou ES, Sampogna F, Fania L, Di Lella G, Panebianco A, Abeni D, Ricci F. Quality of life in caregivers of melanoma patients. Eur J Dermatol. 2022 Nov 1;32(6):698-702. PMID: 36856375
  25. Samela T, Raimondi G, Sampogna F, Ricci F, Fania L, Mastroeni S, Fusari R, Salcedo NM, Dattolo A, Papanikolaou ES, Abeni D. Testing some psychometric properties of the Italian version of the Skin Cancer Index: A questionnaire for measuring quality of life in patients with non-melanoma skin cancer. Front Psychol. 2022 Nov 22;13:991080. PMID: 36483696
  26. Moretta G, Samela T, Sampogna F, Ricci F, Carlesimo F, Panebianco A, D’Erme AM, Di Lella G, Pallotta S, Dellambra E, Abeni D, Fania L. Attitudes among dermatologists regarding actinic keratosis treatment options. Dermatol Reports. 2022 Jan 31;14(3):9392
  27. Gatti V, Fierro C, Compagnone M, La Banca V, Mauriello A, Montanaro M, Scalera S, De Nicola F, Candi E, Ricci F, Fania L, Melino G, Peschiaroli A. ΔNp63-Senataxin circuit controls keratinocyte differentiation by promoting the transcriptional termination of epidermal genes. Proc Natl Acad Sci U S A. 2022 Mar 8;119(10):e2104718119. PMID: 35235452
  28. Fortugno P, Monetta R, Belli M, Botti E, Angelucci F, Palmerini MG, Annarita NS, De Luca C, Ceccarini M, Salvatore M, Bianchi L, Macioce P, Teson M, Ricci F, Network IUD, Macchiarelli G, Didona B, Costanzo A, Castiglia D, Brancati F. RIPK4 regulates cell-cell adhesion in epidermal development and homeostasis. Hum Mol Genet. 2022 Aug 17;31(15):2535-2547.PMID: 35220430
  29. Mancini M, Cappello A, Pecorari R, Lena AM, Montanaro M, Fania L, Ricci F, Di Lella G, Piro MC, Abeni D, Dellambra E, Mauriello A, Melino G, Candi E. Involvement of transcribed lncRNA uc.291 and SWI/SNF complex in cutaneous squamous cell carcinoma. Discov Oncol. 2021 May 3;12(1):14. PMID: 3520147
  30. Fania L, Samela T, Moretta G, Ricci F, Dellambra E, Mancini M, Sampogna F, Panebianco A, Abeni D. Attitudes among dermatologists regarding non-melanoma skin cancer treatment options. Discov Oncol. 2021 Sep 7;12(1):31. PMID: 35201447
  31. Paradisi A, Ricci F, Abeni D, Sonego G. Repair of a Surgical Defect Involving the Nasal Tip. Dermatol Surg. 2021 May 11. PMID: 33988554
  32. Ricci F, Abeni D. Heterogeneity of reports about the impact of the COVID-19 pandemic on melanoma diagnosis. Br J Dermatol. 2022 Aug;187(2):135-136. PMID: 35610054
  33. Ricci F, Di Lella G, Fania L, Ricci F, Sobrino L, Pallotta S, Panebianco A, Fortes C, Abeni D. Primitive melanoma and COVID 19 are we still paying the price of the pandemic? J Eur Acad Dermatol Venereol. 2021 Dec 20. PMID: 34928528
  34. Mastroeni S, Sampogna F, Salcedo NM, Ricci F, Fania L, Antonelli F, Abeni D, Cristofolini M. Factors associated with sunbed use among 3692 outpatients in 18 centers of the Italian Cancer League (LILT). Sci Rep. 2021 Nov 30;11(1):23180. PMID: 34848741
  35. Fortes C, Mastroeni S, Capuano M, Ricozzi I, Bono R, Ricci F, Pagnanelli G, Nudo M. Correction to: Differences in individual and environmental factors between cutaneous melanoma and atypical Spitz tumour in children and adolescents. Eur J Pediatr. 2022 Jan;181(1):271. PMID: 34716799
  36. Dellambra E, Carbone ML, Ricci F, Ricci F, Di Pietro FR, Moretta G, Verkoskaia S, Feudi E, Failla CM, Abeni D, Fania L. Merkel Cell Carcinoma. Biomedicines. 2021 Jun 23;9(7):718.
  37. Di Nardo L, Pellegrini C, Di Stefani A, Ricci F, Fossati B, Del Regno L, Carbone C, Piro G, Corbo V, Delfino P, De Summa S, Maturo MG, Rocco T, Tortora G, Fargnoli MC, Peris K. Molecular alterations in basal cell carcinoma subtypes. Sci Rep. 2021 Jun 24;11(1):13206. PMID: 34168209
  38. Fania L, Sampogna F, Ricci F, Hyeraci M, Paradisi A, Palese E, Di Lella G, Pallotta S, Panebianco A, Candi E, Dellambra E, Abeni D. Systemic Photoprotection in Skin Cancer Prevention: Knowledge among Dermatologists. Biomolecules. 2021 Feb 23;11(2):332. PMID: 33672113
  39. Fania L, Ricci F, Paradisi A, Palese E, Di Lella G, Iemboli ML, Mazzanti C, Pallotta S, Panebianco A, Lembo L, Candi E, Dellambra E, Abeni D. Scarce knowledge of systemic photoprotection among skin cancer patients: a cross-sectional survey. Eur J Dermatol. 2021 Feb 12. PMID: 33586658
  40. Fania L, Didona D, Di Pietro FR, Verkhovskaia S, Morese R, Paolino G, Donati M, Ricci F, Coco V, Ricci F, Candi E, Abeni D, Dellambra E. Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines. 2021 Feb 9;9(2):171. PMID: 33572373
  41. Sampogna F, Paradisi A, Iemboli ML, Fania L, Ricci F, Napolitano M, Abeni D. Sex Differences in Health-related Quality of Life in Patients with Keratinocyte Carcinomas. Acta Derm Venereol. 2020 Dec 29. PMID: 33372685
  42. Paradisi A, Waterboer T, Ricci F, Sampogna F, Pawlita M, Abeni D. Concomitant seropositivity for HPV 16 and cutaneous HPV types increases the risk of recurrent squamous cell carcinoma of the skin. Eur J Dermatol. 2020 Oct 13. PMID: 33052107
  43. Fania L, Provini A, Rota L, Mazzanti C, Ricci F, Panebianco A, Ricci F, Ruggeri S, Didona B. Eosinophilic Annular Erythema: Report Of Four Cases. Dermatol Ther. 2020 Oct 7:e14369. PMID: 33025705
  44. Paradisi A, Abeni D, Didona D, Ricci F, Canzona F, Didona B. A new case series on etanercept treatment for toxic epidermal necrolysis. Eur J Dermatol. 2020 Oct 6. PMID: 33021477
  45. Paradisi A, Ricci F, Sbano P. Severe rhinophyma treated with double wavelengths carbon dioxide-GaAs laser: a case series. Int J Dermatol. 2020 Aug 18. PMID: 32810289
  46. Ricci F, Fania L, Paradisi A, Di Lella G, Pallotta S, Sobrino L, Panebianco A, Annessi G, Abeni D. Delayed melanoma diagnosis in the COVID-19 era: Increased breslow thickness in primary melanomas seen after the COVID-19 lockdown. J Eur Acad Dermatol Venereol. 2020 Aug 11. PMID: 32780876
  47. Paolino G, Bearzi P, Pampena R, Longo C, Frascione P, Rizzo N, Raucci M, Carbone A, Cantisani C, Ricci F, Didona D, Frattini F, Bulotta A, Gregorc V, Mercuri SR. Clinicopathological and dermoscopic features of amelanotic and hypomelanotic melanoma: a retrospective multicentric study. Int J Dermatol. 2020 Jul 29. PMID: 32726478
  48. Fortes C, Mastroeni S, Caggiati A, Passarelli F, Ricci F, Michelozzi P. High level of TILs is an independent predictor of negative sentinel lymph node in women but not in men. Arch Dermatol Res. 2020 Apr 8. PMID: 32266533
  49. Moro F, Ricci F, Pennacchia I, Mazzanti C, Abeni D, Fania L. A Case of Miliaris Osteoma Cutis in a Male: Dermoscopic Findings and Micro-Ablation Treatment. Dermatol Ther. 2019 Jul 31:e13046. PMID: 31365174
  50. Sampogna F, Paradisi A, Iemboli ML, Ricci F, Sonego G, Abeni D. Comparison of quality of life between melanoma and non-melanoma skin cancer patients. Eur J Dermatol. 2019 Apr 1;29(2):185-191. PMID: 31106760
  51. Ricci F, Paradisi A, Fania L, Pallotta S, Di Lella G, Sobrino L, Panebianco A, Abeni D. High melanoma risk in non-melanoma skin cancer patients under age 40: a large retrospective cohort study. G Ital Dermatol Venereol. 2019 Apr 23. [Epub ahead of print] PMID: 31042854
  52. Fania L, Abeni D, Esposito I, Spagnoletti G, Citterio F, Castriota M, Ricci F, Apponi F, Moro F, Mazzanti C, De Simone C, Peris K. Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. Eur J Dermatol. 2018 Oct 15. PMID: 30325318
  53. Fania L, Abeni D, Esposito I, Spagnoletti G, Citterio F, Romagnoli J, Castriota M, Ricci F, Moro F, Perino F, Mazzanti C, De Simone C, Peris K. Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients. G Ital Dermatol Venereol. 2018 Sep 24. PMID: 30251802
  54. Fania L, Ruggeri S, Sordi D, Oliva A, Provini A, Ricci F, Mazzanti C. Sweet syndrome following a positive mantoux test due to pulmonary tuberculosis. Dermatol Ther. 2018 Sep 20:e12754. [Epub ahead of print] PMID: 30238576
  55. Schiavone G, Paradisi A, Ricci F, Abeni D. Injectable Platelet-, Leukocyte-, and Fibrin-Rich Plasma (iL-PRF) in the Management of Androgenetic Alopecia. Dermatol Surg. 2018 Jul 17. [Epub ahead of print] PMID: 30045107
  56. Neri L, Peris K, Longo C, Calvieri S, Frascione P, Parodi A, Eibenschuz L, Bottoni U, Pellacani G; Actinic Keratosis – TReatment Adherence INitiative (AK-TRAIN) study group. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy. J Eur Acad Dermatol Venereol. 2018 Jun 19. PMID: 29920789
  57. Ricci F, Passarelli F, Fiorentini S, Di Lella G. “Interdigital pilonidal sinus in a hairdresser” a case report. Dermatol Ther. 2018 Mar 13. PMID: 29532975
  58. Ricci F, Panebianco A, Fania L, Sobrino L, Sampogna F, Pallotta S, Paradisi A, Abeni D. Age-specific prevalence of psoriasis in an unselected sample of 25,956 Italian hospital inpatients: evidence for selective excess mortality after 70 years of age. Eur J Dermatol. 2018; 28: 103-105. PMID: 29171403
  59. Ricci F, Paradisi A, Maier SA, Kovacs M, Podda M, Peris K, Abeni D. Melanoma and tattoos: a case report and review of the literature. Eur J Dermatol. 2018;  28:50-55. PMID: 29171408
  60. Fania L, Guerriero C, Ricci F, Gagliano MF, De Simone C. Herpes gestationis and oral contraceptive: Case report and review of the literature. Dermatol Ther. 2017; 30 (5). PMID: 28730612
  61. Paradisi A, Didona B, Tabolli S, Ricci F, Sobrino L, Panebianco A, Abeni D. Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study. Eur J Dermatol. 2017 May 19. PMID: 28524053
  62. Rigante D, Fastiggi M, Ricci F, D’Errico F, Bracci B, Guerriero C. Handy Hints About Raynaud’s Phenomenon in Children: A Critical Review. Pediatr Dermatol. 2017; 34:235-239. PMID: 28523890
  63. Ricci F, Lunghi F, De Simone C, Peris K. Propofol-induced irreversible hair depigmentation: a case report. Int J Dermatol. 2017 Mar 27. PMID: 28349515
  64. Fania L, Ricci F, Sampogna F, Mazzanti C, Didona B, Pintori G, Abeni D. Prevalence and incidence of hidradenitis suppurativa: An exercise on indirect estimation from psoriasis data. J Eur Acad Dermatol Venereol. 2017 Mar 16. PMID: 28300328
  65. Paradisi A, Sonego G, Ricci F, Abeni D. Reconstruction of a Lateral Upper Lip Defect. Dermatol Surg. 2018; 44: 291-294. PMID: 27984324
  66. Ricci F, Paradisi A, Annessi G, Paradisi M, Abeni D. Eruptive disseminated Spitz nevi. Eur J Dermatol. 2017; 27: 59-62. PMID: 27758761
  67. Ricci F, De Simone C, Del Regno L, Peris K. Drug-induced hair colour changes. Eur J Dermatol. 2016; 26: 531-36. PMID: 27545142
  68. Paradisi A, Ricci F, Sonego G, Abeni D. Reading man flap to repair malar skin defects. J Am Acad Dermatol. 2016; 75:e31-3. PMID: 27317542
  69. Paradisi A, Ricci F, Sbano P. “Drug-resistant granuloma faciale”: treatment with carbon dioxide-GaAs laser. Dermatol Ther. 2016; 29:317-19. PMID: 27272475
  70. Ricci F, Tambone S, Neri L, Fania L, Piccioni A, Guerriero C, Fargnoli MC, Peris K. Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study. J Dermatolog Treat. 2016, 27: 525:530. PMID: 27043050
  71. Bersani G, Guerriero C, Ricci F, Valentini P, Zampino G, Lazzarreschi I, Antuzzi D, Rigante D. Extensive irregular Mongolian blue spots as a clue for GM1 gangliosidosis type 1. J Dtsch Dermatol Ges. 2016 Jan 14. PMID: 26765271
  72. Ricci F, Masini F, Fossati B, Frascione P, De Waure C, Capizzi R, Guerriero C. Combination therapy with hydrogen peroxide (4%), salicylic acid (0.5%) and D-panthenol (4%): efficacy and skyn tolerability in common acne vulgaris during sun exposure period. Eur Rev Med Pharmacol Sci 2016;20:232-6. PMID: 26875890
  73. Mariani M, Rigante D, Guerriero C, Ricci F, Sani I, Rossodivita A. Progressive osseous heteroplasia in a 7-year-old girl with osteoma cutis and autoimmune thyroiditis: the importance of investigating GNAS mutations. J Eur Acad Dermatol Venereol. 2016: 30: 905-7. PMID: 25752801
  74. Masini F, Ricci F, Fossati B, Frascione P, Capizzi R, De Waure C, Guerriero C. Combination therapy with retinaldehyde (0.1%) glycolic acid (6%) and efectiose (0.1%) in mild to moderate acne vulgaris during the period of sun exposure – efficacy and skin tolerability. Eur Rev Med Pharmacol Sci. 2014; 18:2283-6. PMID: 25219827
  75. Paradisi A, Abeni D, Bergamo F, Ricci F, Didona D, Didona B. Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 2014; 71:278-83.PMID: 24928706
  76. Ricci F, Paradisi A, Silveri SL, Sampogna F, Miccichè F, Bonomo PL, DiNapoli N, Valentini V, Capizzi R, Guerriero C. Adverse skin reactions during treatment with cetuximab plus radiotherapy: Multidisciplinary approach to minimize radio-chemotherapy interruption. J Dermatol Treat 2015; 26: 183-7. PMID: 24852820
  77. Ricci F, Paradisi A, Fossati B, Mancini M, Curatolo P, Guerriero C, Capizzi R. Giant neglected squamous cell carcinoma of the skin. Dermatol Ther. 2015 2015; 28:230-4. PMID: 25754304
  78. Ricci F, Paradisi A, Perino F, Capizzi R, Paolucci V, Rendeli C, Guerriero C. Jacquet erosive diaper dermatitis: a not so rare syndrome. Eur J Dermatol 2014; 24:252-3. PMID: 24721379
  79. Perino F, Ricci F, Favoriti N, Fossati B, Capizzi R, Guerriero C. Ashy dermatosis in pediatric age. Report of a new case: clinical, histological and dermoscopic features. Clinical Dermatology 2014; 2 :110-113. doi:10.11138/cderm/2014.2.2.110
  80. Ricci F, Paradisi A, Masini F, Contaldo I, Battaglia DI, Capizzi R, Guerriero C. Acneiform eruption induced by ethosuximide. Eur J Dermatol 2014; 24:98-9. PMID: 24334200
  81. Paradisi A, Capizzi R, Ricci F, Di Pietro C, Abeni D, Tabolli S. Quality of life in patients with anogenital warts. Eur J Dermatol 2013; 23:837-42. PMID: 24192222
  82. Paradisi A, Ricci F, Fossati B, De Simone C, Capizzi R, Guerriero C. An unusual case of Koebner phenomenon. Eur J Dermatol 2013; 23:529-30. PMID: 24001569
  83. Castriota M, Ricci F, Paradisi A, Fossati B, De Simone C, Capizzi R, Guerriero C. Erythema nodosum induced by kerion celsi of the scalp in a child: a case report and mini-review of literature. Mycoses 2013; 56:200-3. PMID: 23121556
  84. Ricci F, Guerriero F, Paradisi A, Fossati B, Miccichè F, Valentini V, Capizzi R. Multiple abscesses in a patient treated with cetuximab. Eur J Dermatol 2013; 23:103-4. PMID: 23238287
  85. Ricci F, Paradisi A, Silveri SL, Fossati B, Pennacchia I, Massi G, Capizzi R, Guerriero C. Primitive polypoid granular cell tumor. Eur J Dermatol 2012; 22:574-5 PMID: 22652435
  86. Guerriero C, Ricci F, Paradisi A, Fossati B, Valentini V, Pacelli F, Capizzi R. Subcutaneous abscess as a side-effect of cetuximab therapy. Eur J Dermatol 2011; 21:277-8
  1. “Acne Scar Treatment” A. Rusciani, F. Ricci, G. Curinga. European Handbook of Dermatological   Treatments (Andreas Katsambas, Torello Lotti, Clio Dessinioti, Angelo Massimiliano D’Erme) terza edizione; capitolo 108, pp 1073-1080
  2. “Terapia medica dei carcinomi cutanei” Peris K e Ricci F. ebook iDerm SICS editore
  • SIDEMAST (Società Italiana di Dermatologia medica, chirurgica, estetica E delle Malattie Sessualmente Trasmesse) 
  • ADOI (Associazione Dermatologi Ospedalieri Italiani) – Referente regione LAZIO
  • EADV (European Academy of Dermatology and Venereology)
  • IMI (Intergruppo Melanoma Italiano) – Responsabile Commissione tecnologie innovative